Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Inv. presentation Auditor change
|
Cellular Biomedicine Group, Inc. (CBMG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/25/2021 |
GN
| SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm |
01/08/2021 |
GN
| MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm |
12/28/2020 |
GN
| Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout |
12/12/2020 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – CBMG, MVC, STND, EIDX |
11/25/2020 |
GN
| Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm – GLIBA, CBMG, MVC, PTI |
11/13/2020 |
GN
| SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Investigations; Investors are Encouraged to Contact the Firm – CBMG, MVC, PTI, CGIX |
11/06/2020 |
GN
| ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – GLIBA, CBMG, VRTU, MOBL |
11/03/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BSTC, CBMG, CIT, and STND Buyouts |
10/21/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, MYOK, and CBMG Mergers |
10/19/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, CBMG, CIT, and STND Mergers |
10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Cellular Biomedicine Group, Inc., and Eidos Therapeutics, Inc. |
10/14/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers |
10/12/2020 |
GN
| SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of VRTU, CBMG, TNAV, STRS; Shareholders are Encouraged to Contact the Firm |
10/09/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NTN, VRTU, CBMG, and PTI Mergers |
10/02/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and Varian Medical Systems, Inc. (NYSE: VAR) |
09/24/2020 |
GN
| Moore Kuehn Encourages BDGE, CBMG, CGIX, and BMCH Investors to Contact Law Firm |
09/22/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts |
09/02/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts |
09/01/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc., GCI Liberty, Inc., Jernigan Capital, Inc., and NTN Buzztime, Inc. |
08/25/2020 |
GN
| CELLULAR BIOMEDICINE (CBMG) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Cellular Biomedicine Group, Inc. |
08/18/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Delmarva Bancshares, Inc. (DLMV), Maxim Integrated Products (MXIM), and Otelco Inc. (NASDAQ: OTEL) |
08/14/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Montage Resources Corporation (NYSE: MR), Noble Energy, Inc. (NASDAQ: NBL), and Otelco Inc. (NASDAQ: OTEL) |
08/12/2020 |
GN
| CELLULAR BIOMEDICINE GROUP, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
12/18/2018 |
GN
| Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board |
11/06/2018 |
GN
| Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights |
10/25/2018 |
GN
| Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai |
10/03/2018 |
GN
| Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors |
09/24/2018 |
GN
| Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference |
08/28/2018 |
GN
| Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference |
08/08/2018 |
GN
| Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights |
06/22/2018 |
GN
| Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland |
06/21/2018 |
GN
| Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia |
03/23/2018 |
GN
| Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders |
03/21/2018 |
GN
| CBMG????????????AlloJoin™???????I?????????????????? |
|
|
|